Next Article in Journal
Impact of the COVID-19 Pandemic on the Management of Staphylococcus aureus Bloodstream Infections in a Tertiary Care Hospital
Previous Article in Journal
Snapshot of Phenotypic and Molecular Virulence and Resistance Profiles in Multidrug-Resistant Strains Isolated in a Tertiary Hospital in Romania
Previous Article in Special Issue
Evolution of Rabies Virus Isolates: Virulence Signatures and Effects of Modulation by Neutralizing Antibodies
 
 
Review
Peer-Review Record

Avian Influenza: Strategies to Manage an Outbreak

Pathogens 2023, 12(4), 610; https://doi.org/10.3390/pathogens12040610
by Alison Simancas-Racines 1,2,3, Santiago Cadena-Ullauri 2, Patricia Guevara-Ramírez 2, Ana Karina Zambrano 2,* and Daniel Simancas-Racines 3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pathogens 2023, 12(4), 610; https://doi.org/10.3390/pathogens12040610
Submission received: 16 March 2023 / Revised: 27 March 2023 / Accepted: 4 April 2023 / Published: 17 April 2023
(This article belongs to the Special Issue Emerging and Re-emerging Viral Infectious Diseases)

Round 1

Reviewer 1 Report

 Simancas-Racines et al. reported avian influenza with particular attention to the strategies to manage outbreaks. The review is very interesting and well-organized. However,  I recommend adding a chapter about vaccination. 

Other minor revision:

- Family and orders should be in italics (Orthomyxoviridae (line 94), Anseriformes, and Charadriiformes (line 187)).

- Line 119:  Low pathogenic avian influenza virus should be LPAI

-. Line 132: highly pathogenic influenza should HPAI 

- Line 98: Please describe the virus. " The segmented nature of the influenza virus genome leads to emerging of new viruses through genetic reassortment, making its prevention and control more difficult (Parvin et al. 2022; Doi: https://doi.org/10.51585/gjm.2022.3.0016). 

 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Avian influenza virus (AIV) is a type of IAV that is isolated from and adapted to avian host species, and it is classified as low or highly pathogenic. Highly pathogenic avian influenza viruses continue to pose a huge threat to global animal and human health. This review is nicely written and the structure of the document is logical, I have only minor comments that authors could consider.

Specific comments

·         In the abstract is mentioned that “Moreover, AI is a notifiable animal disease; hence all countries must report infections by LPAI and HPAI to the health authorities.”. However, only HPAI (or H5 and H7 LPAI) are notifiable disease. Please clarify this point.

·         Section 2.1. Etiology: Include influenza D virus.

·         Section 2.4.2. Zoonotic transmission, lines 171-172 “Certain mammals can act as reservoirs”. Please, mention which ones or at least a few examples as pigs….

·         Sometimes it is unclear if the proposes measures are recommendation for international organizations (WOAH, FAO, others…). Measures already established in some countries….Please clarify.

·         Lines 413-414 “AI viruses manage to cross the interspecies barrier through a series of antigenic adaptations generated by viral nucleoproteins in the cellular matrix “. This sentence is unclear, please consider rephrasing.

·         It can be great if authors include a section regarding vaccination, advantages/disadvantages for vaccination policies, eg difficulties for trade after vaccination, surveillance tasks, etc….

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop